ArticleFrontiers in public health2025
Survival analysis of pneumoconiosis patients in Jiangsu Province from 1960 to 2024.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Long-term survival and the critical role of competing risks in pneumoconiosis: a large-scale retrospective cohort study.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Pneumoconiosis is recognized as a major occupational health burden worldwide, especially in developing countries where industrial dust exposure is prevalent. This study aims to provide evidence for the development of prevention and control strategies and the strengthening of patient support systems. Methods: Data for this study were sourced from the Jiangsu Province Pneumoconiosis Follow-up Online Reporting System. Survival analysis was performed employing life tables and the Kaplan-Meier method. The Cox proportional hazards regression models were deployed to identify factors influencing pneumoconiosis patients' survival time. Results: A total of 18,064 patients were diagnosed with pneumoconiosis in Jiangsu Province between 1960 and 2024. Life table analysis revealed an overall cumulative survival rate of 40%. Both mortality and hazard ratios increased with advancing age. Patients with Stage III pneumoconiosis had a significantly lower survival rate compared with those in stages I and II ( Conclusion: Our findings highlight the importance of strengthening prevention and control measures targeting high-risk populations and key industries. Strategies should focus on early detection, timely diagnosis, and active intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.